June 5, 2005
A-Detailing from www.skintherapyletter.ca
1     
Elidel®
SkinTherapyLetter
Dosing
Efficacy
Compliance
 Links
Patient Profiles
Introduction
Clinical Experience
Cost of Treatment
Side-Effects, Safety and Risks
Indications
A-Detail™
Next Slide
Authors
Elidel®
Pimecrolimus
A novel topical calcineurin inhibitor for atopic dermatitis
Dr. Yves Poulin, MD, FRCPC
Laval University, Quebec City, Canada
Dr. Stuart Maddin, MD, FRCPC
University of B.C., Vancouver, BC